Living together. Living better.

Children from five to 11 years old can now receive the vaccine too since the European Medicines Agency (EMA) has approved the Comirnaty vaccine, by Pfizer/BioNTech.

To a lesser extent, children have been affected by the pandemic caused by the covid-19 virus; the risks of contracting the infection are obviously different for them and very low in children who don’t suffer from particular pathologies. The vaccine will be released in Germany from December 20, and it’s recommended for children who suffer from obesity, immunodeficiency, chronic lung disease, heart and kidney failure, diabetes mellitus, or who have congenital heart deficits. The vaccine efficiency is 90.7% from the second injection and the dosage, in the case of children, is different. In fact, only ten micrograms per dose are required.

Even though children are generally less contagious than adults, it has been estimated that vaccinating them could reduce the number of infections by approximately 8%. Observed side effects are not particularly remarkable in children who are healthy and without disease, and the benefits of vaccination outweigh the risks. The President of the Standing Committee on Vaccination (Stiko) reassures skeptical parents. According to clinical studies, the vaccine is in fact effective and safe.